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section was also included.
Results: 85% and 98% of students agreed or strongly agreed that anatomy
is an interesting subject and an important component of medical educa-
tion respectively. 63% agreed or strongly agreed that Anatomage signiﬁ-
cantly improved their understanding of 3D anatomy. 78% agreed or
strongly agreed that the interactive nature of Anatomage made learning
anatomy more engaging. Anatomage rated 4th out of 5 anatomy learning
modalities. A large proportion of students volunteered that they needed
more time at the Anatomage table.
Conclusion: Anatomage can play an important role in the acquisition of 3D
anatomy knowledge and promises to be a useful adjunct to traditional
learning modalities, which still rank highly. Early surveys reveal that stu-
dents desire more time at the table to fully realise the educational po-
tential of this technology.
0939: AN OVERVIEW OF TEAMWORK TRAINING AND ASSESSMENT IN
MODERN SURGICAL PRACTICE
G. Whittaker 1,*, H. Abboudi 2, M. Khan 2, P. Dasgupta 2, K. Ahmed 2. 1King's
College London, UK; 2Guy's and St Thomas' NHS Foundation Trust, UK
Aim: To provide an overview of teamwork training and assessment tools
available for surgery and review the internal validation evidence support-
ing each tool, with subsequent formation of a framework for team training.
Methods: A comprehensive literature search was conducted to identify
teamwork assessment tools using MEDLINE® (1946 to December 2014),
EMBASE® (1974 to December 2014), and PsycINFO® (1806 to December
2014) databases. The following keywords were used in combination:
“teamwork”, “team work”, “team-working”, “non-technical skills”,
“nontechnical skills”; “assessment”, “assessing”; “surgery”, “surgical”, and
“surgeons”. Validation evidence was gathered using a similar search,
combining each tool with “validation”, “validity”, and “valid” keywords.
Results: 590 publications and conference abstracts of potential relevance
were discovered and subsequently screened to identify seven tools. Each
tool has at least one item of evidence supporting validity, though the
number and quality varies greatly. The Non-Technical Skills for Surgeons
(NOTSS) tool demonstrated the highest level of validity and has also shown
reliability and acceptability in practice.
Conclusion: Teamwork training and assessment are important aspects of
clinical practice which should be core themes of current surgical curricula.
Integration of the NOTSS tool into early surgical training should be
encouraged to meet evolving requirements of surgeons.Medical Student Short Paper Session0087: INCIDENCE AND OUTCOMES OF POLYOMAVIRUS INFECTION IN
639 KIDNEY TRANSPLANT RECIPIENTS: ARE HIGH IMMUNOLOGICAL
RISK CHARACTERISTICS MORE RELEVANT THAN SPECIFIC INDUCTION
OR MAINTENANCE IMMUNOSUPPRESSIVE REGIMENS?
L. Harris 1,*, J. Worsfold 1, E. Favi 2, E. Aboutaleb 2, R. Cacciola 2, C.
Puliatti 2, C. Sammartino 2, R. Sivaprakasam 2. 1Barts and The London
School of Medicine and Dentistry, UK; 2 The Royal London Hospital, UK
Aim: Polyomavirus-associated nephropathy (PVAN) is a recognized cause
for graft dysfunction and allograft loss. Over-immunosuppression is the
main risk factor for the development of PVAN but the role of donor and
recipient characteristics is still unclear.
Methods: In this single centre cohort study we prospectively collected
data to evaluate incidence, outcomes and risk factors of Polyomavirus
infection in 639 consecutive KTx performed between 2007 and 2013.
Results: During amean follow up of 4.5 years, viraemiawas detected in 54/
639 patients (8.4%); 26/639 recipients (4.1%) had biopsy-proven PVAN.
Death-censored graft loss rate was signiﬁcantly higher in patients with
PVAN compared to recipients with no viraemia: 41.7% (10/24) vs.14.5% (76/
523), respectively (p < 0.05). After immunosuppression reduction, 43/54
patients (79.6%) had no signiﬁcant viraemia; four patients (7.4%) had acuterejection, two (3.7%) had ureteric stenosis. The independent risk factors
were: recipient BMI, Afro-Caribbean recipient ethnicity, older donor age,
higher DR&overallmismatch, and biopsy proven acute rejection (p< 0.05).
Conclusion: Our results show that PVAN signiﬁcantly reduces kidney
allograft survival and identiﬁes a need for post-transplant aggressive
screening, earlier intervention and also supports our hypothesis that high
immunological risk characteristics are more relevant than immunosup-
pressive regimens.0131: PRE-MORBID FUNCTION AND CO-MORBIDITY PREDICT SHORT
AND MID-TERM OUTCOMES FOLLOWING RUPTURED ABDOMINAL
AORTIC ANEURYSM (RAAA) REPAIR
A. Srinivasan 2,*, G. Ambler 1, M.S. Gohel 1, K. Varty 1, P.D. Hayes 1, J.R.
Boyle 1, P. Coughlin 1. 1Addenbrookes Hospital, UK; 2University of
Cambridge, UK
Aim: Strategies for improving outcomes for patients with rAAA are
becoming more evident especially given the aging population. This study
aimed to integrate measures of function alongside co-morbidity to
determine outcome.
Methods: Patients treated for a rAAA over 8 years were assessed. De-
mographics, mortality and requirement for institutional care following
discharge (RICD) were recorded, as well as a variety of measures of func-
tion and co-morbidity. The primary outcome was one-year mortality.
Outcome models were generated using multivariate logistic regression
and were compared to models of vascular frailty.
Results: 182 patients were treated with a 30-day and one-yearmortality of
22.5% and 32.4% respectively. The optimal model for one-year mortality
utilised the Katz score, polypharmacy, visual impairment, anaemia and
statin use. ROC curve analysis revealed this a good predictor of one-year
mortality (area under ROC curve (AUC) ¼ 0.78). The model offered
signiﬁcantly improved prediction of mortality over models of vascular
frailty (P < 0.001).
Conclusion: This novel rAAA model incorporating function and co-
morbidity offers good predictive power for mortality. It is quick to calculate
and may ultimately become helpful for both patient counselling/selection
and comparative audit at a time when outcome in patients with rAAA
increasingly comes under the spotlight.
0506: IS THE ENDOSCOPIC THIRD VENTRICULOSTOMY SCORE AN
APPROPRIATE TOOL TO INFORM CLINICAL DECISION-MAKING? A
NATIONAL MULTI-INSTITUTIONAL EXTERNAL VALIDATION STUDY
R.W. Foley*, L.V. Gorman, S. Ndoro, D. Crimmins, J. Caird. Children’s
University Hospital Dublin, Ireland
Aim: To evaluate the performance of the Endoscopic Third Ven-
triculostomy Success Score (ETV-SS) in an independent cohort of patients
from the Republic of Ireland.
Methods: Prospectively collected data on all paediatric ETV procedures
performed in Ireland between 2008 and 2014 were analysed. The cohort
consisted of 112 consecutive patients less than 16 years of age who had
undergone ETV for the treatment of hydrocephalus. The percentage
chance of success at 6 months was calculated as per the ETV-SS.
Results: At 6 months the success rate of ETV in this cohort was 61%.
Dividing the cohort into low (<30%), intermediate (40e70%) and high-risk
(<70%) categories demonstrated good calibration between predicted
probabilities and actual outcome. The AUC for the ETV-SS was 0.60.
Conclusion: The ETV-SS has demonstrated clinical utility in this national
cohort of patients and can be used to predict the outcome of ETV. The ETV-
SS can be employed in clinical practice to inform the decision to proceed to
ETV and facilitate the discussion with parents as to the likelihood of the
procedure being a successful treatment strategy.
0553: MORTALITY AND INFECTION ASSOCIATED WITH EXTERNAL
VENTRICULAR DRAINS (EVD) IN A REGIONAL NEUROSURGICAL UNIT
C. O' Brien 2,*, E. Broughton 1. 1Derriford Hospital, UK; 2 Peninsula College of
Medicine and Dentistry, UK
